Definitive Contract 75F40120C00135
Award Date
9/29/20
Potential Completion Date
9/29/23
Potential Value
$347K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
622110 - General Medical and Surgical Hospitals
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP) for "Targeted Clinical Research to Address Select Viral Infections." The $5,835,169.39 definitive contract is for a 7-year period ending in May 2024. It does not have a set-aside designation. Under this contract, CHOP leads a multi-site observational study on human adenovirus...
The U.S. Food and Drug Administration (FDA) awarded a $87,181 firm-fixed-price purchase order contract to The Children's Hospital of Philadelphia (CHOP) to study the "Natural History of Enteroviral Sepsis Using Real World Data". The contract has an ultimate completion date of August 31, 2023. CHOP, a leading pediatric hospital and research facility, will leverage its expertise in areas such as infectious diseases to contribute to this federal healthcare initiative. The contract does...
This is a definitive, firm fixed-price contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to The Children's Hospital of Philadelphia (CHOP) Research Institute on September 30, 2017 for a value of $322,263.00. The contract does not have a set-aside designation and is for the performance of "OTHER FUNCTIONS" with a completion date of June 30, 2019. CHOP is a pediatric healthcare provider, research institution, and...
This is a Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Administration, a civilian agency, to The Children's Hospital of Philadelphia (CHOP) Research Institute. The contract has a ceiling value of $99,455.90 and an ultimate completion date of January 25, 2018. The contract was not set aside. CHOP is a leading pediatric hospital and research facility that provides clinical care, conducts research, and trains future leaders in child health. Through...
The Children's Hospital of Philadelphia (CHOP) has been awarded a Definitive Contract by the Food and Drug Administration (FDA) for $1,048,942.00 to conduct research and development on drug development for pediatric cancers. The contract is a renewal of the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory Science, which seeks proposals across areas of regulatory science to modernize research and support the FDA's mission. The contract has no set-aside designation. As a leading...
This is a $276,916.98 federal contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP) Research Institute. The contract, which is a definitive contract with cost-no-fee pricing, is for the National Children's Study. The contract does not have a set-aside designation. As a leading pediatric hospital and research institution, CHOP leverages...
This is a federal contract award to The Children's Hospital of Philadelphia (CHOP) from the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the Department of Health and Human Services. The $18,779,641.25 definitive contract is for research and development facilities, with a period of performance ending on March 31, 2010. The contract does not have a set-aside designation. CHOP, a leading pediatric hospital and research facility, is the prime...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI) to The Children's Hospital of Philadelphia (CHOP) Research Institute. The contract, valued at $369,057.08, is for core activities related to GTRP AAV Vector Production Core Lab, Task Area A. The contract does not have a set-aside designation. CHOP, a leading pediatric hospital and research facility, has been awarded numerous federal contracts and grants to conduct research and...
This is a $393,676.59 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Children's Hospital of Philadelphia (CHOP) Research Institute. The contract is for GTRP AAV lab services in support of the NEI (National Eye Institute) for fiscal year 2014, and has a period of performance through June 1, 2017. The contract is not a set-aside and is a Cost No Fee type arrangement. CHOP is a leading...
This is a $19,010.20 firm-fixed-price purchase order contract awarded to The Children's Hospital of Philadelphia (CHOP) by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services. The contract is for DNA extraction, amplicon library preparation, and next-generation sequencing services, including a 10% surcharge for academic services. The contract has no set-aside designation and does not reference a larger vehicle. CHOP, a leading...